Chandigarh-based Venus Remedies celebrates its UK market authorization for Bleomycin 15,000 IU, a potent cancer-fighting medication. With 15 global approvals and ongoing efforts to expand access, the company is dedicated to enhancing cancer care and improving the lives of patients worldwide.